InMode Ltd. Ordinary Shares (INMD) Stock: Buy, Sell, or Hold?
INMD - InMode Ltd. Ordinary Shares
$14.08
0.38 (2.77%)
▲
5d:
+3.68%
30d:
-0.35%
90d:
-7.43%
BUY
HIGH Confidence
Analysis Updated: Nov 3, 2026 12:00 AM ET
Earnings: Nov 11, 2026
7d
Get Alerted When INMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: INMD shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: INMD shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$16.77
Based on 5.0% avg growth
INTRINSIC VALUE TODAY
$10.41
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 9.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: INMD is currently trading at $14.08, which is considered fair relative to its 30-day fair value range of $13.72 to $14.29. The stock's valuation (Forward PE: 10.0) is in line with its historical norms (9.6). At these levels, the market is pricing in 1.3% annual earnings growth.
Technical Outlook: Technically, INMD is in a downtrend. The price is approaching resistance at $14.17. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: INMD scores 70/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $16.17 (+18.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, INMD is in a downtrend. The price is approaching resistance at $14.17. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: INMD scores 70/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $16.17 (+18.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$13.72 -
$14.29
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
87.3%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (70/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($16.17)
- BULLISH: Expecting earnings turnaround to 1.3% growth with None% revenue growth
- BULLISH: Bottoming setup score 70/100 — corrected, stabilizing, and turning up
Trading Range Analysis
30-Day Trading Range
$13.72 -
$14.29
Current vs Trading Range
FAIR
Expected Move (7 Days)
±$0.77
(5.5%)
Support & Resistance Levels
Support Level
$13.19
Resistance Level
$14.17
Current Trend
Downtrend
Technical data as of
Nov 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
9.99
Wall Street Target
$16.17
(+18.0%)
Earnings Growth (YoY)
-31.0%
Profit Margin
20.7%
Valuation Premium vs History
+1.3% premium
PE vs Historical
10.0 vs 9.6
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+1.3%
(market-implied from PE analysis)
1-Year Target
$13.88
(+1%)
2-Year Target
$14.06
(+3%)
3-Year Target
$14.24
(+4%)
3-Yr Target (if PE normalizes)
(PE: 10→10)
PE COMPRESSION
$13.69
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 5.9%)
$32.33
(+136%)
Base:
(SPY PE: 10.0, Growth: 5.9%)
$16.25
(+19%)
Bear:
(PE: 8.5, Growth: 5.9%)
$13.82
(+1%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (11x PE), but valuation improves significantly next year (10x PE) as earnings recover.
Trailing PE: 10.93 | Current EPS (TTM): $1.21
Bull Case
$16.49
(+20%)
Analyst growth 13.4%, PE expands to 12.0
Base Case
$14.99
(+9%)
Market implied 13.4%, PE stable at 10.9
Bear Case
$8.99
(-34%)
Severe decline -20.0%, PE contracts to 9.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: November 03, 2026 3:42 PM ET
Data refreshes hourly during market hours. Next update: 4:42 PM
Data refreshes hourly during market hours. Next update: 4:42 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is INMD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
BUY
31 analysts |
$51 | 52 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
28 analysts |
$119 | 44 HOLD |
|
EW
Edwards Lifesciences Corp |
STRONG BUY
30 analysts |
$102 | 40 SELL |
|
MDT
Medtronic PLC |
BUY
30 analysts |
$105 | 45 HOLD |
|
ATEC
Alphatec Holdings Inc |
STRONG BUY
14 analysts |
$14 | 59 HOLD |
Advanced INMD Option Strategies
Professional options setups generated by AI based on today's INMD price and gamma walls.
